Who is sponsoring NCT00737516?

NCT00737516 is sponsored by National Marrow Donor Program.

What condition does NCT00737516 study?

NCT00737516 studies Leukemia, Lymphoma, Myelodysplastic Syndromes.

What drugs are being tested in NCT00737516?

Interventions: HPC, Cord Blood.

What is the status of NCT00737516?

NCT00737516 is currently COMPLETED.

Last reviewed 2013-06-12 · How we verify

A Centralized Cord Blood Registry to Facilitate Allogeneic, Unrelated Donor Umbilical Cord Blood Transplantation

NCT00737516 Phase 2 COMPLETED

The National Marrow Donor Program (NMDP) has established a system for registering, matching, and tracking unrelated donor cord blood units (CBUs) and transplant outcomes. Study subjects are donors who enroll through collaborating cord blood banks. This study creates uniform collection, screening, testing and storage requirements for cord blood units. The purpose of standardization is to improve efficiency in the selection of cord blood units for transplantation.

Details

Lead sponsor	National Marrow Donor Program
Phase	Phase 2
Status	COMPLETED
Enrolment	3621
Start date	2000-01
Completion	2011-10

Conditions

Leukemia
Lymphoma
Myelodysplastic Syndromes

Interventions

HPC, Cord Blood

Primary outcomes

Study safety and efficacy for treatment for malignant and non-malignant disorders — annually

Countries

United States